Maze Therapeutics Common Stock Price Patterns
| MAZE Stock | 47.71 2.68 5.95% |
Momentum 62
Buy Extended
Oversold | Overbought |
EPS Estimate Current Year (3.07) | EPS Estimate Next Year (3.15) | Wall Street Target Price 49.4444 |
Using Maze Therapeutics hype-based prediction, you can estimate the value of Maze Therapeutics Common from the perspective of Maze Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Maze Therapeutics using Maze Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Maze using crowd psychology based on the activity and movement of Maze Therapeutics' stock price.
Maze Therapeutics Implied Volatility | 1.33 |
Maze Therapeutics' implied volatility exposes the market's sentiment of Maze Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Maze Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Maze Therapeutics stock will not fluctuate a lot when Maze Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Maze Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Maze because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Maze Therapeutics after-hype prediction price | USD 46.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Maze contract
Based on the Rule 16, the options market is currently suggesting that Maze Therapeutics Common will have an average daily up or down price movement of about 0.0831% per day over the life of the 2026-05-15 option contract. With Maze Therapeutics trading at USD 47.71, that is roughly USD 0.0397 . If you think that the market is fully incorporating Maze Therapeutics' daily price movement you should consider acquiring Maze Therapeutics Common options at the current volatility level of 1.33%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Maze Therapeutics Basic Forecasting Models to cross-verify your projections. Maze Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Maze Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Maze Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Maze Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Maze Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Maze Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Maze Therapeutics' historical news coverage. Maze Therapeutics' after-hype downside and upside margins for the prediction period are 42.73 and 49.85, respectively. We have considered Maze Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Maze Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Maze Therapeutics Common is based on 3 months time horizon.
Maze Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Maze Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Maze Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Maze Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.60 | 3.53 | 1.24 | 0.01 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
47.71 | 46.29 | 2.80 |
|
Maze Therapeutics Hype Timeline
Maze Therapeutics Common is now traded for 47.71. The entity has historical hype elasticity of 1.24, and average elasticity to hype of competition of -0.01. Maze is forecasted to increase in value after the next headline, with the price projected to jump to 46.29 or above. The average volatility of media hype impact on the company the price is about 171.36%. The price growth on the next news is projected to be 2.8%, whereas the daily expected return is now at 0.6%. The volatility of related hype on Maze Therapeutics is about 17650.0%, with the expected price after the next announcement by competition of 47.70. Maze Therapeutics Common currently holds 26.63 M in liabilities. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Maze Therapeutics Basic Forecasting Models to cross-verify your projections.Maze Therapeutics Related Hype Analysis
Having access to credible news sources related to Maze Therapeutics' direct competition is more important than ever and may enhance your ability to predict Maze Therapeutics' future price movements. Getting to know how Maze Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Maze Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZYME | Zymeworks Common Stock | 0.76 | 11 per month | 2.90 | 0.06 | 5.40 | (4.72) | 36.09 | |
| ARDX | Ardelyx | (0.11) | 9 per month | 3.02 | 0.07 | 8.50 | (5.04) | 25.22 | |
| PHVS | Pharvaris BV | (1.45) | 7 per month | 3.53 | 0.06 | 6.58 | (6.01) | 27.81 | |
| BCRX | BioCryst Pharmaceuticals | 0.07 | 9 per month | 0.00 | (0.06) | 4.49 | (4.19) | 16.75 | |
| IMNM | Immunome | (0.45) | 11 per month | 4.13 | 0.12 | 7.87 | (6.71) | 31.45 | |
| SYRE | Spyre Therapeutics | 0.60 | 8 per month | 2.48 | 0.15 | 7.15 | (4.47) | 20.03 | |
| SION | Sionna Therapeutics Common | (0.89) | 8 per month | 5.36 | 0.01 | 7.92 | (8.89) | 31.39 | |
| NTLA | Intellia Therapeutics | 1.02 | 12 per month | 6.05 | (0) | 10.73 | (8.64) | 33.96 | |
| WVE | Wave Life Sciences | 0.74 | 8 per month | 4.09 | 0.09 | 6.72 | (6.18) | 164.47 | |
| TRVI | Trevi Therapeutics | (0.49) | 7 per month | 3.00 | 0.02 | 6.73 | (5.03) | 25.67 |
Maze Therapeutics Additional Predictive Modules
Most predictive techniques to examine Maze price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Maze using various technical indicators. When you analyze Maze charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Maze Therapeutics Predictive Indicators
The successful prediction of Maze Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Maze Therapeutics Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Maze Therapeutics based on analysis of Maze Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Maze Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Maze Therapeutics's related companies. | 2023 | 2024 | 2025 (projected) | PB Ratio | 69.45 | 3.55 | 4.08 | Capex To Depreciation | 0.11 | 0.35 | 0.4 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Maze Stock analysis
When running Maze Therapeutics' price analysis, check to measure Maze Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maze Therapeutics is operating at the current time. Most of Maze Therapeutics' value examination focuses on studying past and present price action to predict the probability of Maze Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maze Therapeutics' price. Additionally, you may evaluate how the addition of Maze Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |